SE8501882D0 - Pyridinderivat och framstellning derav - Google Patents

Pyridinderivat och framstellning derav

Info

Publication number
SE8501882D0
SE8501882D0 SE8501882A SE8501882A SE8501882D0 SE 8501882 D0 SE8501882 D0 SE 8501882D0 SE 8501882 A SE8501882 A SE 8501882A SE 8501882 A SE8501882 A SE 8501882A SE 8501882 D0 SE8501882 D0 SE 8501882D0
Authority
SE
Sweden
Prior art keywords
preparation
pyridine derivatives
vasodilating
formulaand
dihydropyridine
Prior art date
Application number
SE8501882A
Other languages
English (en)
Other versions
SE464028B (sv
SE8501882L (sv
Inventor
K Kimura
I Morita
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of SE8501882D0 publication Critical patent/SE8501882D0/sv
Publication of SE8501882L publication Critical patent/SE8501882L/sv
Publication of SE464028B publication Critical patent/SE464028B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8501882A 1984-04-19 1985-04-17 1,4-dihydropyridin-3-karboxylat, saett att framstaella denna och en farmaceutisk komposition SE464028B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59079560A JPS60248693A (ja) 1984-04-19 1984-04-19 ピリジン誘導体及び製法

Publications (3)

Publication Number Publication Date
SE8501882D0 true SE8501882D0 (sv) 1985-04-17
SE8501882L SE8501882L (sv) 1985-10-20
SE464028B SE464028B (sv) 1991-02-25

Family

ID=13693390

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8501882A SE464028B (sv) 1984-04-19 1985-04-17 1,4-dihydropyridin-3-karboxylat, saett att framstaella denna och en farmaceutisk komposition

Country Status (15)

Country Link
US (1) US5036059A (sv)
EP (1) EP0159040B1 (sv)
JP (1) JPS60248693A (sv)
KR (1) KR850007603A (sv)
AT (1) ATE83237T1 (sv)
AU (1) AU570552B2 (sv)
BE (1) BE902210A (sv)
DE (1) DE3586879D1 (sv)
ES (1) ES8606276A1 (sv)
FR (1) FR2563222B1 (sv)
GB (1) GB2157695A (sv)
IT (1) IT1209945B (sv)
NL (1) NL8500909A (sv)
SE (1) SE464028B (sv)
ZA (1) ZA852591B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6163688A (ja) * 1984-08-03 1986-04-01 Nissan Chem Ind Ltd ジヒドロピリジン−5−ホスホン酸環状エステル類
CN1016063B (zh) 1986-01-22 1992-04-01 日产化学工业株式会社 二氢吡啶-5-膦酸环亚丙基酯的制备
US4885284A (en) * 1986-01-22 1989-12-05 Nissan Chemical Industries Ltd. Dihydropyridine-5-phosphonic acid cyclic propylene ester
UA5590A1 (uk) * 1986-01-23 1994-12-28 Ніссан Кемікал Індастріз Лтд Спосіб одержання пропіленглікового ефіру заміщеної 1,4-дігідропіріділ-5-фосфорної кислоти, або його фармацевтично прийнятной солі або сольвата
JPS63115890A (ja) * 1986-10-31 1988-05-20 Nippon Shinyaku Co Ltd 2位置換1,4−ジヒドロピリジン誘導体
JPH01275591A (ja) * 1988-04-27 1989-11-06 Nissan Chem Ind Ltd ジヒドロピリジン−5−ホスホン酸誘導体
CA1334752C (en) * 1988-08-02 1995-03-14 Ryozo Sakoda Drug effect-enhancing agent for antitumor drug
JP2850376B2 (ja) * 1988-08-02 1999-01-27 日産化学工業株式会社 抗癌剤薬効増強剤
US20020119201A1 (en) * 2000-09-08 2002-08-29 Novozymes A/S Lubricated granules
KR100870527B1 (ko) 2003-03-28 2008-11-26 닛산 가가쿠 고교 가부시키 가이샤 T형 칼슘 채널 저해제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2094678A5 (sv) * 1970-06-30 1972-02-04 Pepro
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS59161392A (ja) * 1983-03-04 1984-09-12 Nippon Shinyaku Co Ltd ジヒドロピリジン誘導体及びその製法
DE3477669D1 (en) * 1983-09-26 1989-05-18 Nissan Chemical Ind Ltd Dihydropyridine-5-phosphonic acid cyclic ester

Also Published As

Publication number Publication date
JPS60248693A (ja) 1985-12-09
EP0159040A3 (en) 1988-08-17
ES542378A0 (es) 1986-04-01
IT1209945B (it) 1989-08-30
GB8507897D0 (en) 1985-05-01
FR2563222B1 (fr) 1989-06-09
AU570552B2 (en) 1988-03-17
SE464028B (sv) 1991-02-25
EP0159040B1 (en) 1992-12-09
KR850007603A (ko) 1985-12-07
BE902210A (fr) 1985-10-17
ES8606276A1 (es) 1986-04-01
NL8500909A (nl) 1985-11-18
ATE83237T1 (de) 1992-12-15
JPH0259835B2 (sv) 1990-12-13
SE8501882L (sv) 1985-10-20
FR2563222A1 (fr) 1985-10-25
AU4140585A (en) 1985-10-24
EP0159040A2 (en) 1985-10-23
GB2157695A (en) 1985-10-30
IT8547862A0 (it) 1985-03-25
ZA852591B (en) 1986-01-29
US5036059A (en) 1991-07-30
DE3586879D1 (de) 1993-01-21

Similar Documents

Publication Publication Date Title
IT7928464A0 (it) Composizione farmaceutica avente attivita' antitumorale.
DK343980A (da) 2,4,6-triiod-isophthalsyrederivater
ES479271A1 (es) Un procedimiento para la preparacion de compuestos derivados de acido tioetianico.
DK109487D0 (da) Fungicid paa basis af et cyanopyrrolderivat
SE8501882D0 (sv) Pyridinderivat och framstellning derav
FR2347381A1 (fr) Nouveaux derives d'anthracycline-glycosides, en particulier designes sous le nom d'antibiotiques ma 144-m1 et ma 144-m2, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits composes comme agents antitumeurs
IT7948449A0 (it) Derivati di 3,3-dicloro-2-azetidino ne ad attivita' anti-infiammatoria
IT1199212B (it) Derivati dell'1,2-ditiolano,loro preparazione e loro impiego come medicamenti
IT7922150A0 (it) Derivati dell'isochinolina, loro preparazione, e composizioni farmaceutiche che li contengono.
IT7825497A0 (it) Derivati di 1,2,4-ossadiazolo, loro preparazione e loro applicazione in terapia.
RU1797460C (ru) Нематоцидное средство
NL7804509A (nl) Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
SE8705035L (sv) Anvaendning av alkylglycerol
IT8020503A0 (it) Derivati della 1,1'-bifenil-2-ilalchilammina ad azione farmaceutica.
FR2358403A1 (fr) Nouveaux 2-imino-1,3-benzodithiolannes utiles notamment comme anti-inflammatoires
NL7602363A (nl) N.n'-difenylguanidinederivaten.
IT8721657A0 (it) Eteri e tioeteri ad attivita'terapeutica, loro preparazione e composizioni che li contengono.
ES8504779A1 (es) Procedimiento de obtencion de nuevos derivados de 1h-imidazol
IT7822047A0 (it) Derivati d'acidi furoil-o tenoil-naftilossialchil-carbossilici, loro preparazione e loro impiego come medicamenti.
SE9003704D0 (sv) New selenophen derivatives, a preparation process of the samme and therapeutical compositions containing them
FR2362865A1 (fr) Derives de la 2,2'-cyclocytidine, leur preparation et leurs utilisations therapeutiques comme agents anti-cancer
IT1216830B (it) Derivati 1,4-diidropiridinici quali agenti emoreologici
IT7949944A0 (it) Derivati di dossorubicina dotati di attivita' antitumorale procedimento per la loro preparazione e composizioni che li contengono
PT70177A (de) 3,4-dihydroxyzimtaldehydderivat dessen herstellung und arzneimittel
FR2320088A1 (fr) Derives de l'arginine, leur preparation et leurs utilisations therapeutiques

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8501882-8

Effective date: 19931110

Format of ref document f/p: F